Business
Vor Files IPO Registration Statement on Nasdaq
Vor Files IPO Registration Statement on Nasdaq.
About this update from Puretech Health Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 9392L\n PureTech Health PLC\n 18 January 2021\n \n \n \n \n 18 January 2021\n \n \n PureTech Health plc\n \n \n \n \n \n PureTech Founded Entity Vor Files Public Registration Statement for Proposed Initial Public Offering\n \n \n \n \n \n PureTech Health plc\n \n (LSE: PRTC, NASDAQ: PRTC)\n \n announced\n that its Founded Entity, Vor Biopharma Inc. (\"Vor\"), \n has filed a public registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. \n Vor\n intends to list its common stock under the symbol \"\n VOR\n \" on The Nasdaq Global Market.\n \n \n \n \n \n Goldman Sachs & Co. LLC is the lead book runner for the proposed offering.\n \n \n \n \n \n A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. The offering will be made only by means of a prospectus. When available, a copy of the preliminary prospectus may be obtained by visiting the SEC's website at www.sec.gov or by contacting the offices of Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone: 1-866-471-2526 or by emailing [email protected].\n \n \n \n \n \n This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.\n \n \n \n \n \n Cautionary Note Regarding Forward-Looking Statements\n \n \n This press release contains statements that are or may be forward-looking statements, including statements that relate to our product candidates and approach towards addressing maj...